New York, NY, April 30, 2019 --(PR.com
)-- This event is scheduled for Monday, May 20, 2019 @ 12:00 pm - 2:00 pm (ET).
For further details, please visit: https://www.theknowledgegroup.org/webcasts/navigating-mass-torts-litigation/
About Timothy L. Krippner
Timothy L. Krippner is a shareholder in Segal McCambridge Singer & Mahoney’s Chicago office. A career trial attorney, Mr. Krippner has held the role of trial, local, regional and national coordinating counsel while representing manufacturers in a myriad of product liability and toxic tort matters nationally. His successful practice includes considerable experience defending general product liability, professional liability, medical malpractice and construction matters as well. Mr. Krippner is a frequent speaker often called upon to present on emerging issues related to mass tort litigation. He currently serves on Segal McCambridge’s Strategic Planning Committee and, over the course of his career at the firm, has served on its Executive, Marketing and Budget Committees during a period of growth where the firm expanded from one local office in Chicago to offices in Austin, Detroit, Houston, Jersey City, New York, Philadelphia, and St. Louis.
About Segal McCambridge Singer & Mahoney, Ltd.
Segal McCambridge Singer & Mahoney, Ltd. is a national firm of trial lawyers representing and counseling clients in product liability, toxic tort, complex commercial, employment, insurance coverage, construction, environmental, professional liability, transportation, technology and cyber risk, and warranty matters. Founded in 1986, Segal McCambridge has grown from a four-lawyer shop in Chicago to more than 130 attorneys with offices in Austin, Chicago, Detroit, Houston, Jersey City, New York City, Philadelphia and St. Louis.
A large number of mass torts filed over the previous year involve drugs including Xarelto, Risperdal, Opioids and Pradaxa. One notable case is the mass tort against pharmaceutical giant Hoffmann La-Roche with over 500 lawsuits claiming that users of the company’s acne drug Accutane, developed inflammatory bowel disease. The New Jersey Supreme Court ruled in favor of Hoffmann La-Roche with its dismissal of the mass tort case. The Court said that the plaintiffs failed to prove that Roche failed to provide internal research to the Food and Drug Administration (FDA).
Understanding mass tort case verdicts such as this, as well as the upcoming ones, is critical in devising effective litigation strategies.
Join a panel of key thought leaders and professionals assembled by The Knowledge Group as they bring the audience to a road beyond the basics of bringing or defending against a mass tort lawsuit and as they delve into the depth-analysis of the current trends and recent court rulings. Speakers will also provide the audience with practical strategies in bringing out the best in these lawsuits in a rapidly evolving legal climate.
Some of the major topics that will be covered in this course are:
Mass Torts Litigation – Overview and Statistics
Recent Trends and Developments
Notable Cases and Verdicts
Top Issues and Challenges
Best Litigation Strategies
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/